People with type 2 diabetes face heightened risks for heart attack and stroke, as well as progressive kidney disease. But a new once-a-week injected drug called efpeglenatide could greatly reduce their odds for those outcomes, new research shows. The clinical trial was… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is […]
Dementia patients who have the same nurse for all of their home health care visits are a third less likely to be readmitted to the hospital, a new study finds. “While continuity of nursing care may benefit every home health care patient, it may be particularly critical for… Read Full Article (External Site) Dr. David […]
There is no doubt that as we age, the battle of the bulge becomes tougher. Our metabolism slows down, stress builds up causing hormone imbalances, and we tend to be more sedentary in general. “As you age, your metabolism slows down, and a lot of your metabolism functions and… Read Full Article (External Site) Dr. […]
© 2024 BETTER/SMARTER.ME, A division of the Institute for the Future of Human Potential
200 First St. SW Rochester, MN 55905 | 1-800-328-IFHP
IFHRP research has not been evaluated by the Food and Drug Administration or any government agency.
IFHRP research is not intended to diagnose, treat, cure, or prevent disease.